Also known as Tarceva
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche. In lung cancer, it extends life by an average of 3.3 months.Source: Wikipedia
Estimated Total Cost: $3702.83 for an average of 28 days supply
Patients are most commonly prescribed erlotinib to treat lung cancer, metastatic cancer, pancreatic cancer, and fatigue.
Patients taking erlotinib most commonly experience side effects like skin rash, fatigue, and shortness of breath.